Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Urban Novak

Showing results (61-70 of 103) with videos related to

Pageof 11
Sort By:
Radiation Oncology (London, England)|December 24, 2017
Highly conformal combined radiotherapy with cisplatin and gemcitabine for treatment of loco-regionally advanced cervical cancer - a retrospective studyNikola Cihoric, Alexandros Tsikkinis, Eugenia Vlaskou Badra, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 25, 2009
BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphomaMasumichi Saito, Urban Novak, Erich Piovan, et al.
JAMA Network Open|March 2, 2021
Association of Supporting Trial Evidence and Reimbursement for Off-Label Use of Cancer DrugsAmanda Katherina Herbrand, Andreas M Schmitt, Matthias Briel, et al.
International Journal of Molecular Sciences|March 11, 2023
Small Cellular Particles from European Spruce Needle HomogenateMarko Jeran, Anna Romolo, Vesna Spasovski, et al.
Journal of Cancer Research and Clinical Oncology|August 23, 2022
The role of immune checkpoint inhibitors in clinical practice: an analysis of the treatment patterns, survival and toxicity rates by sexMurielle N Wahli, Stefanie Hayoz, Dennis Hoch, et al.
Cancers|June 12, 2026
A Phase Ib Trial of Copanlisib in Combination with Venetoclax in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma-SAKK 66/18 TrialMaria Cristina Pirosa, Dagmar Hess, Fatime Krasniqi, et al.
ESMO Open|December 6, 2019
Contrasting evidence to reimbursement reality for off-label use (OLU) of drug treatments in cancer care: rationale and design of the CEIT-OLU projectAmanda Katherina Herbrand, Andreas Michael Schmitt, Matthias Briel, et al.
EJNMMI Physics|April 13, 2026
Contrast-enhanced CT for attenuation correction in ultra-high sensitivity long-axial field-of-view lymphoma PET: amplified quantification problems?Jan-Luca Penner, August Blomgren, Alexander Weissensee, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 2, 2025
<sup>161</sup>Tb Radioimmunotherapy as a Treatment for CD30-Positive LymphomasElisa Rioja-Blanco, Yara Banz, Christoph Schlapbach, et al.
Experimental Hematology|July 17, 2020
Analysis of IL-6 serum levels and CAR T cell-specific digital PCR in the context of cytokine release syndromeThomas Pabst, Raphael Joncourt, Evgenii Shumilov, et al.
Pageof 11

Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
Radiation Oncology (London, England)|December 24, 2017
Highly conformal combined radiotherapy with cisplatin and gemcitabine for treatment of loco-regionally advanced cervical cancer - a retrospective studyNikola Cihoric, Alexandros Tsikkinis, Eugenia Vlaskou Badra, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 25, 2009
BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphomaMasumichi Saito, Urban Novak, Erich Piovan, et al.
JAMA Network Open|March 2, 2021
Association of Supporting Trial Evidence and Reimbursement for Off-Label Use of Cancer DrugsAmanda Katherina Herbrand, Andreas M Schmitt, Matthias Briel, et al.
International Journal of Molecular Sciences|March 11, 2023
Small Cellular Particles from European Spruce Needle HomogenateMarko Jeran, Anna Romolo, Vesna Spasovski, et al.
Journal of Cancer Research and Clinical Oncology|August 23, 2022
The role of immune checkpoint inhibitors in clinical practice: an analysis of the treatment patterns, survival and toxicity rates by sexMurielle N Wahli, Stefanie Hayoz, Dennis Hoch, et al.
Cancers|June 12, 2026
A Phase Ib Trial of Copanlisib in Combination with Venetoclax in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma-SAKK 66/18 TrialMaria Cristina Pirosa, Dagmar Hess, Fatime Krasniqi, et al.
ESMO Open|December 6, 2019
Contrasting evidence to reimbursement reality for off-label use (OLU) of drug treatments in cancer care: rationale and design of the CEIT-OLU projectAmanda Katherina Herbrand, Andreas Michael Schmitt, Matthias Briel, et al.
EJNMMI Physics|April 13, 2026
Contrast-enhanced CT for attenuation correction in ultra-high sensitivity long-axial field-of-view lymphoma PET: amplified quantification problems?Jan-Luca Penner, August Blomgren, Alexander Weissensee, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 2, 2025
<sup>161</sup>Tb Radioimmunotherapy as a Treatment for CD30-Positive LymphomasElisa Rioja-Blanco, Yara Banz, Christoph Schlapbach, et al.
Experimental Hematology|July 17, 2020
Analysis of IL-6 serum levels and CAR T cell-specific digital PCR in the context of cytokine release syndromeThomas Pabst, Raphael Joncourt, Evgenii Shumilov, et al.
Pageof 11